Table 2 Stroke pathway performance pre-post COVID-19 pandemic
From: Stroke pathway performance assessment: a retrospective observational study
Pre-Covid (Mar-Dec 2019) | Covid (Mar-Dec 2020) | Total | p | |||
|---|---|---|---|---|---|---|
Number of patients | 69 | 66 | 135 | |||
% | 51.1 | 48.9 | 100.0 | |||
Age at stroke onset | Mean | 75.75 | 75.00 | 75.39 | 0.761 | |
Std. Deviation | 14.498 | 14.061 | 14.239 | |||
Onset-to-Door (OTD) | Mean | 88.13 | 118.48 | 102.22 | 0.197 | |
Std. Deviation | 78.844 | 171.927 | 130.871 | |||
Door-to-Imaging CT/MR (DTI) | Mean | 32.93 | 32.66 | 32.81 | 0.956 | |
Std. Deviation | 20.605 | 31.773 | 26.012 | |||
Door-to-Needle (DTN) | Mean | 61.49 | 63.44 | 62.44 | 0.673 | |
Std. Deviation | 26.553 | 26.902 | 26.642 | |||
Modified Ranking Scale (mRS) (Baseline) | Mean | 0.72 | 1.18 | 0.95 | 0.048 | |
Std. Deviation | 1.162 | 1.499 | 1.351 | |||
NIHSS (Baseline) | Mean | 10.32 | 10.84 | 10.52 | 0.725 | |
Std. Deviation | 7.329 | 7.693 | 7.442 | |||
NIHSS (24 h) | Mean | 5.24 | 5.57 | 5.33 | 0.852 | |
Std. Deviation | 6.715 | 7.208 | 6.809 | |||
Modified Ranking Scale after 3 months (mRS 3 m) | Mean | 2.76 | 2.44 | 2.62 | 0.520 | |
Std. Deviation | 2.257 | 2.576 | 2.395 | 0.761 | ||